New Zealand: Market for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses 2022

Market Size for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in New Zealand

In 2021, the New Zealand human and animal blood market decreased by -X% to $X for the first time since 2017, thus ending a three-year rising trend. Overall, consumption, however, saw a buoyant increase. Over the period under review, the market hit record highs at $X in 2015; however, from 2016 to 2021, consumption stood at a somewhat lower figure.

Production of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in New Zealand

In value terms, human and animal blood production shrank to $X in 2021 estimated in export price. In general, production, however, recorded strong growth. The growth pace was the most rapid in 2014 with an increase of X% against the previous year. Human and animal blood production peaked at $X in 2020, and then shrank in the following year.

Exports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Exports from New Zealand

In 2021, human and animal blood exports from New Zealand skyrocketed to X tons, growing by X% compared with 2020 figures. In general, exports recorded a tangible expansion. The pace of growth appeared the most rapid in 2016 with an increase of X% against the previous year. Over the period under review, the exports hit record highs in 2021 and are likely to continue growth in the immediate term.

In value terms, human and animal blood exports skyrocketed to $X in 2021. Overall, exports posted a buoyant increase. The most prominent rate of growth was recorded in 2016 when exports increased by X% against the previous year. Over the period under review, the exports hit record highs in 2021 and are expected to retain growth in the immediate term.

Exports by Country

The United States (X tons) was the main destination for human and animal blood exports from New Zealand, accounting for a X% share of total exports. Moreover, human and animal blood exports to the United States exceeded the volume sent to the second major destination, Australia (X tons), twofold. The third position in this ranking was taken by India (X tons), with a X% share.

From 2012 to 2021, the average annual growth rate of volume to the United States amounted to +X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Australia (+X% per year) and India (+X% per year).

In value terms, the United States ($X), China ($X) and India ($X) appeared to be the largest markets for human and animal blood exported from New Zealand worldwide, with a combined X% share of total exports.

China, with a CAGR of +X%, recorded the highest growth rate of the value of exports, in terms of the main countries of destination over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

The average human and animal blood export price stood at $X per ton in 2021, rising by X% against the previous year. In general, the export price posted strong growth. The most prominent rate of growth was recorded in 2015 when the average export price increased by X% against the previous year. As a result, the export price reached the peak level of $X per ton. From 2016 to 2021, the the average export prices failed to regain momentum.

There were significant differences in the average prices for the major overseas markets. In 2021, the country with the highest price was China ($X per ton), while the average price for exports to Australia ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to China (+X%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Imports into New Zealand

In 2021, purchases abroad of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses increased by X% to X tons, rising for the second consecutive year after two years of decline. Over the period under review, imports, however, saw a slight contraction. The most prominent rate of growth was recorded in 2016 when imports increased by X% against the previous year. Over the period under review, imports attained the peak figure at X tons in 2017; however, from 2018 to 2021, imports stood at a somewhat lower figure.

In value terms, human and animal blood imports stood at $X in 2021. Overall, total imports indicated a buoyant increase from 2012 to 2021: its value increased at an average annual rate of +X% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports increased by +X% against 2019 indices. The pace of growth was the most pronounced in 2013 with an increase of X%. Over the period under review, imports hit record highs in 2021 and are likely to continue growth in the near future.

Imports by Country

In 2021, the United States (X tons) constituted the largest supplier of human and animal blood to New Zealand, accounting for a X% share of total imports. Moreover, human and animal blood imports from the United States exceeded the figures recorded by the second-largest supplier, Australia (X tons), twofold. Denmark (X tons) ranked third in terms of total imports with a X% share.

From 2012 to 2021, the average annual growth rate of volume from the United States totaled +X%. The remaining supplying countries recorded the following average annual rates of imports growth: Australia (-X% per year) and Denmark (-X% per year).

In value terms, the United States ($X) constituted the largest supplier of human and animal blood to New Zealand, comprising X% of total imports. The second position in the ranking was held by Japan ($X), with a X% share of total imports. It was followed by Denmark, with a X% share.

From 2012 to 2021, the average annual growth rate of value from the United States totaled +X%. The remaining supplying countries recorded the following average annual rates of imports growth: Japan (+X% per year) and Denmark (-X% per year).

Import Prices by Country

The average human and animal blood import price stood at $X per ton in 2021, growing by X% against the previous year. Over the period under review, the import price continues to indicate a resilient expansion. The growth pace was the most rapid in 2018 an increase of X%. Over the period under review, average import prices attained the maximum in 2021 and is likely to see steady growth in the immediate term.

There were significant differences in the average prices amongst the major supplying countries. In 2021, the country with the highest price was the UK ($X per ton), while the price for Australia ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Australia (+X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :